ResearcherAzienda Ospedaliera Sant'AndreaActive in the last 2 years
Laura Antolino
Matched on ORCID iD 0000-0002-9559-3595; OpenAlex author ID A5076577738. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers
Papers 8
- Impact of Textbook Oncologic Outcome on long term survival after resection for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.pan.2025.09.004↗
- Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort Co-author DOI 10.3390/onco5040044↗
- Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective Studies. Co-author DOI 10.1007/s11605-021-05190-z↗
- Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective Studies. Co-author DOI 10.1007/s11605-020-04697-1↗
- Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcin… First author DOI 10.1097/sla.0000000000003372↗
- Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? The PaCANOD cohort study protocol. Co-author DOI 10.5301/tj.5000693↗
- Neoadjuvant treatment in pancreatic cancer: Evidence-based medicine? A systematic review and meta-analysis. First author DOI 10.1007/s12032-017-0951-0↗
- Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials. First author DOI 10.1007/s12032-016-0742-z↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Giovanni Ramacciato · 7 shared papers, 2016–2025 · strength 0.81
- Paper Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort DOI 10.3390/onco5040044↗
- Paper Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective S… DOI 10.1007/s11605-021-05190-z↗
- Paper Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemot… DOI 10.1097/sla.0000000000003372↗
- Niccolò Petrucciani · 6 shared papers, 2016–2025 · strength 0.72
- Paper Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort DOI 10.3390/onco5040044↗
- Paper Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective S… DOI 10.1007/s11605-021-05190-z↗
- Paper Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemot… DOI 10.1097/sla.0000000000003372↗
- Francesco D’Angelo · 5 shared papers, 2016–2025 · strength 0.57
- Paper Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort DOI 10.3390/onco5040044↗
- Paper Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective S… DOI 10.1007/s11605-021-05190-z↗
- Paper Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? The PaCANOD cohort study proto… DOI 10.5301/tj.5000693↗
- Giuseppe R. Nigri · 4 shared papers, 2017–2025 · strength 0.52
- Paper Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort DOI 10.3390/onco5040044↗
- Paper Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective S… DOI 10.1007/s11605-021-05190-z↗
- Paper Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective Studies. DOI 10.1007/s11605-020-04697-1↗
- Alessandro Ferrero · 1 shared paper, 2025 · strength 0.30
- Serena Langella · 1 shared paper, 2025 · strength 0.30
- Germana de Nucci · 1 shared paper, 2025 · strength 0.21
- Gianpiero Manes · 1 shared paper, 2025 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.